

Author: Ravindranath M.H. Wood T.F. Soh D. Gonzales A. Muthugounder S. Perez C. Morton D.L. Bilchik A.J.
Publisher: Academic Press
ISSN: 0011-2240
Source: Cryobiology, Vol.45, Iss.1, 2002-08, pp. : 10-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Cryosurgical ablation (CSA) of tumors induces disruptive necrosis. Necrosis may release tumor gangliosides into circulation and they may augment serum antiganglioside antibodies depending on the nature of gangliosides released. The hypothesis is tested by determining the level of serum total gangliosides (STG) and their antibody titers in the sera of colon cancer patients with cryoablated liver tumors. As controls, we examined the sera of patients who underwent radiofrequency ablation (RFA) and regular surgery (RS), none of which cause disruptive necrosis. The STG level (expressed as lipid-bound sialic acids, LBSA) is higher (p2<0.001) in 35 patients (stage IV) than in 38 healthy case-controls (median 23.48 mg/dL, Q-range 7.1 vs 16.04 mg/dL, Q-range 4.5). The mean STG level increased significantly to31.2±6.0 mg/dL (p2<0.03) after CSA. Concomitantly, the IgM titer against colon cancer-associated gangliosides (
Related content






By Zhanaeva S. Korolenko T. Nekrasov B. Nikolin V. Kaledin V.
Bulletin of Experimental Biology and Medicine, Vol. 140, Iss. 4, 2005-10 ,pp. :




By Nickel R. Wahn U. Hizawa N. Maestri N. Duffy D.L. Barnes K.C. Beyer K. Forster J. Bergmann R. Zepp F. Wahn V. Marsh D.G.
Genomics, Vol. 46, Iss. 1, 1997-11 ,pp. :